2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Resendiz-Galvan, J. E., Arora, P. R., Abdelwahab, M. T., Udwadia, Z. F., Rodrigues, C., Gupta, A., ... & Tornheim, J. A. (2023). Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India. Frontiers in Pharmacology, 13, 1081123. https://doi.org/10.3389/fphar.2022.1081123
Chirehwa, M. T., Resendiz-Galvan, J. E., Court, R., De Kock, M., Wiesner, L., de Vries, N., ... & McIlleron, H. (2023). Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial Agents and Chemotherapy, 67(3), e01426-22. https://doi.org/10.1128/aac.01426-22
Waalewijn, H., Szubert, A. J., Wasmann, R. E., Wiesner, L., Chabala, C., Bwakura-Dangarembizi, M., Makumbi, S., Nangiya, J., Mumbiro, V., Mulenga, V., Musiime, V., Monkiewicz, L. N., Griffiths, A. L., Bamford, A., Doerholt, K., Denti, P., Burger, D. M., Gibb, D. M., McIlleron, H. M., … Team, for the C. with H. in A. – P. and A. of S. second-line antiretroviral regimens (CHAPAS-4) T. (2023). First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial. Clinical Infectious Diseases. https://doi.org/10.1093/CID/CIAD267
Abdelgawad, N., Tshavhungwe, M. (Phophi), Rohlwink, U., McIlleron, H., Abdelwahab, M. T., Wiesner, L., Castel, S., Steele, C., Enslin, J. (Nico), Thango, N. S., Denti, P., & Figaji, A. (2023). Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis. Antimicrobial Agents and Chemotherapy, 67(3). https://doi.org/10.1128/AAC.01474-22